The renal function of 7 patients with cor pulmonale and secondary polycythaemia was studied by clearance methods. Their haematocrit (Hct) was initially 62 ± 6% (mean ± SD). Their effective renal plasma flow rates (RPF) were reduced and filtration fractions (FF) increased. They were restudied 5–7 days after Hct reduction to 49 ± 5%. There were no significant changes in glomerular filtration rate (GFR), RPF, FF, effective renal blood flow (RBF) or body weight. However, 5 of 7 patients had a reduction in FF and a fall in body weight. Serial measurements in one patient demonstrated that immediately following the reduction in Hct there was an increase in RPF and a fall in FF, but these reverted to previous levels within 1 week. Overall, a positive correlation was obtained between changes in body weight and FF (r = 0.85, n = 7, p < 0.015). Polycythaemia is only one factor contributing to a low RPF and high FF in patients with cor pulmonale; reduction of the Hct reduces the FF in some patients and leads to a diuresis which may be beneficial in those with fluid retention.

Keywords:
Polycythaemia, Cor pulmonale, Renal blood flow, Glomerular filtration rate
This content is only available via PDF.
© 1982 S. Karger AG, Basel
1982
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.